Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Clinical trial NCT07160179 · RECRUITING
Trial details
- NCT number
- NCT07160179
- Sponsor
- AbbVie
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-13
- Primary completion
- 2029-10-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.